Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus

2013 ◽  
Vol 70 (13) ◽  
pp. 1123-1131 ◽  
Author(s):  
Gina J. Ryan ◽  
Nader H. Moniri ◽  
Dawn D. Smiley
2013 ◽  
Vol 5 (2) ◽  
pp. 98-104
Author(s):  
Takehiro Kawata ◽  
Akira Kanamori ◽  
Akira Kubota ◽  
Hajime Maeda ◽  
Hikaru Amamiya ◽  
...  

2007 ◽  
Vol 4 (4) ◽  
pp. 469-486 ◽  
Author(s):  
Kim E. Innes ◽  
Heather K. Vincent

There is growing evidence that yoga may offer a safe and cost-effective intervention for Type 2 Diabetes mellitus (DM 2). However, systematic reviews are lacking. This article critically reviews the published literature regarding the effects of yoga-based programs on physiologic and anthropometric risk profiles and related clinical outcomes in adults with DM 2. We performed a comprehensive literature search using four computerized English and Indian scientific databases. The search was restricted to original studies (1970–2006) that evaluated the metabolic and clinical effects of yoga in adults with DM 2. Studies targeting clinical populations with cardiovascular disorders that included adults with comorbid DM were also evaluated. Data were extracted regarding study design, setting, target population, intervention, comparison group or condition, outcome assessment, data analysis and presentation, follow-up, and key results, and the quality of each study was evaluated according to specific predetermined criteria. We identified 25 eligible studies, including 15 uncontrolled trials, 6 non-randomized controlled trials and 4 randomized controlled trials (RCTs). Overall, these studies suggest beneficial changes in several risk indices, including glucose tolerance and insulin sensitivity, lipid profiles, anthropometric characteristics, blood pressure, oxidative stress, coagulation profiles, sympathetic activation and pulmonary function, as well as improvement in specific clinical outcomes. Yoga may improve risk profiles in adults with DM 2, and may have promise for the prevention and management of cardiovascular complications in this population. However, the limitations characterizing most studies preclude drawing firm conclusions. Additional high-quality RCTs are needed to confirm and further elucidate the effects of standardized yoga programs in populations with DM 2.


2019 ◽  
Vol 2019 ◽  
pp. 1-25 ◽  
Author(s):  
Rongzi Li ◽  
Yuxian Zhang ◽  
Suhail Rasool ◽  
Thangiah Geetha ◽  
Jeganathan Ramesh Babu

Type 2 diabetes mellitus is a complicated metabolic disorder characterized by hyperglycemia and glucose intolerance. Alzheimer’s disease is a progressive brain disorder characterized by a chronic loss of cognitive and behavioral function. Considering the shared characteristics of both diseases, common therapeutic and preventive agents may be effective. Bioactive compounds such as polyphenols, vitamins, and carotenoids found in vegetables and fruits can have antioxidant and anti-inflammatory effects. These effects make them suitable candidates for the prevention or treatment of diabetes and Alzheimer’s disease. Increasing evidence from cell or animal models suggest that bioactive compounds may have direct effects on decreasing hyperglycemia, enhancing insulin secretion, and preventing formation of amyloid plaques. The possible underlying molecular mechanisms are described in this review. More studies are needed to establish the clinical effects of bioactive compounds.


Sign in / Sign up

Export Citation Format

Share Document